Inhibiting the Fanconi Anaemia pathway to target BRCA1/2 negative breast and ovarian cancers

Therapeutic Innovation Australia 2026 Open access

Read full text
Authors: Therapeutic Innovation Australia
DOI: 10.82292/zt8m-n327
Cited by: 0

Fields of Study & Subjects

PARP inhibition in cancer therapy BRCA gene mutations in cancer DNA Repair Mechanisms

Publication details

Journal / source
Therapeutic Innovation Australia
Publication date
16 February 2026
Language
EN